Karp- Manual de terapia dirigida para el cancer 2.ed

vii

Meredith A. McKean, MD The University of Texas MD Anderson Cancer Center Victoria A. Miller, FNP-BC The University of Texas MD Anderson Cancer Center Sandra Montez, RN The University of Texas MD Anderson Cancer Center Yong H. Moon, MD The University of Texas MD Anderson Cancer Center Shhyam Moorthy, PhD The University of Texas MD Anderson Cancer Center Mariela B. Murphy, MD The University of Texas MD Anderson Cancer Center Aung Naing, MD The University of Texas MD Anderson Cancer Center Robert Orlowski, MD The University of Texas MD Anderson Cancer Center Lance C. Pagliaro, MD Mayo Clinic Shubham Pant, MD The University of Texas MD Anderson Cancer Center Amy B. Patel, PA-C The University of Texas MD Anderson Cancer Center Michael Pearlman, MD, PhD Blue Sky Neurology Naveen Pemmaraju, MD The University of Texas MD Anderson Cancer Center Allan A. L. Pereira, MD, PhD The University of Texas MD Anderson Cancer Center Ashley Perkins, MS The University of Texas MD Anderson Cancer Center Sarina A. Piha-Paul, MD, MS The University of Texas MD Anderson Cancer Center Patrick Pilie, MD The University of Texas MD Anderson Cancer Center Matthew Reilley, MD University of Virginia Jordi Rodon-Ahnert, MD, PhD The University of Texas MD Anderson Cancer Center Jason Roszik, MBA, PhD The University of Texas MD Anderson Cancer Center Shiraj Sen, MD, PhD The University of Texas MD Anderson Cancer Center Jatin J. Shah, MD Karyopharm Therapeutics Arlene O. Siefker-Radtke, MD The University of Texas MD Anderson Cancer Center Raphael Steiner, MD The University of Texas MD Anderson Cancer Center SAMPLE